The Patent Finder

Compositions and Methods for Treating Pulmonary Hypertension

Acceleron Pharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application 62/510,403, filed May 24, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,695,405Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
UsedRemaining
Acceleron Pharma Inc.In forceMedium confidence
US 10,722,558Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,946,067Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,973,880Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 11,065,303Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 11,219,666Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 11,318,188Compositions and Methods for Treating Pulmonary Hypertension
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,497,794Compositions and Methods for Treating Pulmonary Hypertension
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,622,992Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 12,343,378Compositions and Methods for Treating Pulmonary Hypertension
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
2 more records in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
10 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited